FEASIBILITY AND SAFETY OF INDOCYANINE GREEN (ICG) GUIDED SENTINEL LYMPH NODE MAPPING FOR PEDIATRIC SOLID TUMORS - T-LyM (Tumor-Lymph Node Mapping)
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 1 month
Maximum Age: 17
Healthy Volunteers: f
View:
• Any pediatric patient (under the age of 18 years) being treated at the University of Rochester Medical Center, Department of Surgery.
• Diagnosed with pediatric solid tumor
• Scheduled to undergo lymph node sampling as part of their clinical management.
Locations
United States
New York
University of Rochester Medical Center
RECRUITING
Rochester
Contact Information
Primary
Abdelhafeez Abdelhafeez, MD
Abdelhafeez_Abdelhafeez@URMC.Rochester.edu
Time Frame
Start Date: 2026-04-13
Estimated Completion Date: 2028-07-30
Participants
Target number of participants: 10
Treatments
Indocyanine Green (ICG) and KARL STORZ ICG Imaging System
Related Therapeutic Areas
Sponsors
Leads: University of Rochester